| 2022 | Suppression of DYRK1A/B Drives Endoplasmic Reticulum Stress-mediated Autophagic Cell Death Through Metabolic Reprogramming in Colorectal Cancer Cells | ANTICANCER RESEARCH |
| 2021 | Deep-Learning-Based Natural Language Processing of Serial Free-Text Radiological Reports for Predicting Rectal Cancer Patient Survival
| FRONTIERS IN ONCOLOGY |
| 2021 | Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases | EJSO |
| 2021 | Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma
| CANCER RESEARCH AND TREATMENT |
| 2021 | Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS |
| 2021 | Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection
| WORLD ALLERGY ORGANIZATION JOURNAL |
| 2021 | Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View
| YONSEI MEDICAL JOURNAL |
| 2021 | ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | NATURE |
| 2021 | 2020 Korean guidelines for the management of metastatic prostate cancer
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
| FRONTIERS IN ONCOLOGY |
| 2021 | Autonomy is not but competence and relatedness are associated with physical activity among colorectal cancer survivors | SUPPORTIVE CARE IN CANCER |
| 2021 | Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
| FRONTIERS IN ONCOLOGY |
| 2020 | Clinical features and KRAS mutation in colorectal cancer with bone metastasis
| SCIENTIFIC REPORTS |
| 2020 | A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases | CLINICAL COLORECTAL CANCER |
| 2020 | Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY |
| 2020 | Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma | EUROPEAN JOURNAL OF CANCER |
| 2020 | Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection | ANNALS OF SURGICAL ONCOLOGY |
| 2020 | Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy
| CANCER RESEARCH AND TREATMENT |
| 2020 | Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
| TRIALS |
| 2020 | Objectively measured physical activity during chemotherapy in colon cancer patients | SUPPORTIVE CARE IN CANCER |
| 2019 | 위장관암 환자의 옥살리플라틴 항암화학요법으로 인한 말초신경병증, 증상경험, 디스트레스와 삶의 질
| ASIAN ONCOLOGY NURSING |
| 2019 | VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers | Science Immunology |
| 2019 | Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients
| Frontiers in Oncology |
| 2019 | Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection
| Frontiers in Oncology |
| 2019 | Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors
| Journal of Cancer Prevention |
| 2018 | The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer. | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2018 | CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer
| YONSEI MEDICAL JOURNAL |
| 2018 | IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors. | CANCER IMMUNOLOGY RESEARCH |
| 2018 | Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells. | CANCER RESEARCH |
| 2018 | Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
| CANCER RESEARCH AND TREATMENT |
| 2018 | Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
| CANCER RESEARCH AND TREATMENT |
| 2018 | Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection | CLINICAL COLORECTAL CANCER |
| 2018 | Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2018 | YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma | CANCER IMMUNOLOGY RESEARCH |
| 2017 | A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors | INVESTIGATIONAL NEW DRUGS |
| 2017 | Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition | ONCOGENE |
| 2017 | IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
| NATURE COMMUNICATIONS |
| 2017 | Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
| BMC CANCER |
| 2017 | Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancer
| JOURNAL OF RADIATION RESEARCH |
| 2017 | Quality of life among Korean gastrointestinal cancer survivors
| EUROPEAN JOURNAL OF ONCOLOGY NURSING |
| 2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| ONCOLOGY LETTERS |
| 2017 | Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2017 | Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort
| CANCER RESEARCH AND TREATMENT |
| 2017 | Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2016 | Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2016 | Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial
| CANCER RESEARCH AND TREATMENT |
| 2016 | Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers | BRITISH JOURNAL OF CANCER |
| 2016 | A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach
| JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY |
| 2016 | High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
http://orcid.org/0000-0001-5350-7241
(7403647334)
